Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...
Eli Lilly's tirzepatide, sold as Zepbound for weight loss and Mounjaro ... However, shortages remain for the low-dose version of the weight-loss drug Wegovy, the FDA said. The FDA confirmed ...
Lilly has started selling vials of the lowest dose of Zepbound in U.S. through its direct-to-consumer website to improve availability and combat the rise in popularity of compounded versions.
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
Related Lilly cuts price on weight-loss drug Zepbound, selling it in single-dose vials Decision on new Lilly Alzheimer's drug delayed by FDA Eli Lilly names new head of diabetes and obesity ...